Medexus Pharmaceuticals (MDP) Stock Price, News & Analysis

Company Overview

Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.

Key Stats

• Today's Range: C$3.97 to C$4.11
• 50-Day Range: C$3.03 to C$4.13
• 52-Week Range: C$2.47 to C$4.16
• Volume: 13,033 shs
• Average Volume: 49,398 shs
• Market Capitalization: C$131.78 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:MDP
• CIK: N/A
• Web: www.medexus.com
• Phone: 877-633-3987
• Fax: N/A
• Employees: 98
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 24.92
• P/E Growth: N/A
• Net Income: C$3.26 million
• Net Margins: -0.27%
• Pretax Margin: N/A
• Return on Equity: -0.52%
• Return on Assets: 4.89%

Debt

• Debt-to-Equity Ratio: 48.55
• Current Ratio: 1.12
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$99.43 million
• Price / Sales: 1.32
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$1.61 per share
• Price / Book: 2.53

Miscellaneous

• Outstanding Shares: 32,300,000
• Free Float: N/A
• Market Cap: C$131.46 million
• Optionable: Not Optionable
• Beta: 0.57